Skip to main content

Table 2 List of amino acid substations found in this study

From: First report on molecular docking analysis and drug resistance substitutions to approved HCV NS5A and NS5B inhibitors amongst Iranian patients

Mutation NS5A 1a (20) Mutation NS5A 3a (21) NS5B
1a (15)
Mutation NS5B
3a (31)
Mutation
R 44 K 14 (70%) T 7 N 1 (4.7%) N 444 D 12 (80%) N 317 G 27 (87%)
V 75 A 8 (40%) A 17 S 8 (38%) R 300 Q 12 (80%) A 366 P 31 (100%)
R 78 K 14 (70%) A 21 T 10 (47%) Q 309 R 6 (40%) K 389 R 18 (58%)
K 107 T 20 (100%) A 62 S 6 (28.57%) A 327 Q 9 (60%) I 448 V/T 21 (67.7%)
I 121 V 8 (40%) T 64 S 4(19%) H 374 Y 2 (13.3%) A 398 P 4 (12.9%)
R 123 Q 14 (70%) H 85 Y 4 (19%) S 431 G 2 (13.3%) M 436 L 4 (12.9%)
S 131 T 20(100%) S 103 P 6 (28.57%) V432 I 2 (13.3%) D 386 N 12 (38.7%)
I 144 V 20 (100%) N116 S 5 (23.8%) I 434 V 1 (6.6%) K 314 R 9 (29%)
E 171 D 12 (60%) E 137 G 4 (19%) P 461 L 1 (6.6%) R 384 L 9 (29%)
S 174 T 8 (40%) E 137 G 4 (19%) S 335 N 1 (6.6%) P 275 L 2 (6.45%)
E 181 D 15 (75%) D 172 E 8 (38%)    A 315 V 1 (3.22)
L 199 V 8 (40%) M 176 T 6 (28.57%)    T 350 A 1 (3.22)
   H 180 N 9 (42.85%)    A 347 T 2 (6.45%)
   T 183 A 7 (33.33%)    K 314 R 2 (6.45%)
   Q 309 R 6 (40%)    K 387 E 1 (3.22%)
   A 327 Q 9(60%)    D 392 E 1 (3.22%)
       Y 391 C 1 (3.22%)
       T 310 M 1 (3.22%)
       R 343 K 1 (3.22%)
       A 348 V 1 (3.22%)
       A 403 T 1 (3.22%)
       V 490 M 1 (3.22%)